Genentech regulatory update

The Cardiovascular and Renal Drugs Advisory Committee was scheduled to discuss an accelerated dose regimen last Friday. GNE (South San Francisco) said there were no issues with the submission and that all the data has been submitted.

The new label would be for a 90-minute infusion of drug. The current label calls for a three-hour drip plus heparin. ...